Heritage Cannabis Holdings Announces Phase 2 Construction And Advisory Board

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.


Vancouver, B.C. / TheNewswire / January 29, 2018 – HERITAGE CANNABIS HOLDINGS CORPORATION (CSE: CANN) (“Heritage or Company”) is pleased to announce the commencement of Phase 2 construction, and a creation of a three-person Advisory Board.  


Heritage’s 75% owned subsidiary, PhyeinMed Inc. (“PhyeinMed”) a Health Canada late stage applicant under the ACMPR (Access to Cannabis for Medical Purposes Regulations), has begun its Phase 2 build out of a new 41,400 sq ft facility at their Falkland, BC location. This new build is 3,400 sq ft larger than originally planned, and is in addition to their existing 15,500 sq ft facility, which is scheduled for completion in mid-February. It is expected that the construction of Phase 2 will be done by late Spring 2018, with cannabis production beginning June 2018. Upon completion, the production capacity of Phase 1 and 2 will be in excess of 4,000 kg of cannabis flower.


Jagdip Bal, CEO of Heritage commented “Our Falkland project is progressing according to plan, and we have our sights set on completing both the Phase 1 build and evidence package for Health Canada on-time. Additionally, we would like to applaud the new regulations by Health Canada allowing for reduced specification on security requirements, and in anticipation of the proposed regulations for adult use cannabis, adjustments were made regarding our security requirements with huge savings by not committing to a vault but instead a secured storage area has been built.”


The Company would also like to announce the creation of a newly formed Advisory Board. Joining this new board are Michele Cadario, Bob Simmonds, and Debra Senger.


Ms. Cadario is the former Deputy Chief of Staff for both Premier Christy Clark in British Columbia, and the Office of the Prime Minister of Canada.  Currently, Ms. Cadario is the Principal of VANGAURD Strategy, a communications and public relations firm, Ms. Cadario has also held senior positions in Canuck Place Children’s Hospice and the BC Liberal Party.


Mr. Simmonds is a retired RCMP Inspector, after a career which spanned over 36 years, with particular focus in Alberta, targeting illegal marijuana grow operations.  He is a trained security expert surrounding marijuana cultivation, and has conducted training seminars, lectures and presentations both within and outside of the law enforcement community. Mr. Simmonds comes from a distinguished law enforcement family as his father Robert Henry Simmonds, OC was the 17th Commissioner of the Royal Canadian Mounted Police, serving from 1977 to 1987.


Ms. Senger is the President & CEO of PhyeinMed Inc., a 75% subsidiary of Heritage.  The Company has continually relied on Ms. Senger’s significant knowledge of the cannabis industry and her guidance as PhyeinMed created their expansion plans.  


“I am very pleased with the creation of this new Advisory Board.  Being able to add quality people like this to our management team, both furthers our ability to execute on our aggressive strategies, and better validates our position as future leader in the cannabis industry in Canada.” stated Clint Sharples, Chairman of Heritage.  


About Heritage Cannabis Holdings Corporation

The Company is currently listed as a marijuana issuer having a 75% interest in PhyeinMed Inc, a Health Canada late stage applicant under the ACMPR (Access to Cannabis for Medical Purposes Regulations). It is a parent and development company with strategic plans to continue to acquire Cannabis related companies.



“Jag Bal”


Jagdip Bal

President and CEO


For more information contact:

Jag Bal

Tel:  604-628-1767


The Canadian Stock Exchange does not accept responsibility for the adequacy or accuracy of this release.


This news release contains forward-looking information, which involves known and unknown risks, uncertainties and other

factors that may cause actual events to differ materially from current expectation. Important factors - including the availability

of funds, the results of financing efforts, the results of exploration activities -- that could cause actual results to differ materially

from the Company's expectations are disclosed in the Company's documents filed from time to time on SEDAR (see www.sedar.com). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as

of the date of this press release. The company disclaims any intention or obligation, except to the extent required by law, to

update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


Click Image To View Full Size


Copyright (c) 2018 TheNewswire - All rights reserved.